CSR

In pursuit of its human health care philosophy, Eisai China Inc. strives to maintain the highest GMP standard in manufacturing products and strictly adheres to the highest level of ethics and compliance. Through this commitment, Eisai China Inc not only provides high-quality, eco-friendly, safe and satisfactory products and services to patients and their families, but also proactively contribute to society by supporting programs and activities that help promote the advancement of medical sciences (e.g. “Eisai Scholarship Award”), increase awareness about diseases (e.g. “Yellow Handkerchief Love Action”), and provide aide in times of disasters.

 

 

2022

March

Donated medical supplies valued at 450,000 yuan to all medical workers in the Jiang’an district during the COVID-19 epidemic in Shanghai.

 

February

“Hai Yun Xin Sheng” Breast Cancer Patients Support Project

To help more breast cancer patients to gain timely treatment, reduce the economical burden of the patients’ families and lengthen the patients’ lives, the China Primary Health Care Foundation started the “Hai Yun Xin Sheng” Breast Cancer Patients Support Project in Sep 2020. Eisai China provided Eribulin injection (Halaven®) to the foundation for free to help patients gain effective treatment and improve their life quality. By the end of February 2022, the project has helped 207 patients with minimum living standards, 1,833 patients in low-income conditions, and Eisai China has donated 24,955 injections. The total donation amount reached 99 million yuan.

 

January

Awarded the “Top Employer China 2022” and the “WeCare” reward in HRAA

 

2021

December

“Wei Ai Xu Hang” Liver Cancer Patients Support Project

To gain liver cancer patients more effective and timely treatment, reduce their families’ financial costs, and lengthen the patients’ lives, the China Primary Health Care Foundation started the “Wei Ai Xu Hang” Liver Cancer Patients Support Project in Jan 2019. Eisai China provided the medicine Lenvatinib (Lenvima®) for the foundation. The project is aim at helping patients who need Lenvatinib to cure liver cancer to gain a longer and more effective treatment. By the end of December 2021, the project has supported over 26,816 liver cancer patients and Eisai China has donated Lenvatinib over 337,006 boxes in total, which is valued at over 4.5 billion yuan.

 

December

Party-building Excellent Alliance Unit

 

November

2018-2022 Suzhou Civilization Unit

 

August

No. 88 in China’s Top 100 Pharmaceutical Industry Companies in 2020

 

July

Contribution Award For Health Development in County

 

2020

June

“5G Era, Epilepsy Care“, a large public welfare project has been launched.

April

“Hp”-Care for patients, a public welfare projects started smoothly.

March

Donated over 15 million valued cash and goods to Anti-COVID-19 project. Among them, 1 million RMB was donated to Wuhan Charity Federation and it donated medicines with a total value of more than 10.56 million yuan to relevant medical institutions and organizations for the protection and improvement of medical personnel’s autoimmunity, and goods with a total value of 3.89 million yuan from various channels at home and abroad bought protective clothing, isolation clothing, medical surgical masks, eye masks, face masks, goggles, frontal temperature guns, disinfection and sterilization supplies and other supplies.

March

Eisai China Inc. win the title of 2019 most socially responsible enterprises in Suzhou Industrial Park.

February

Initiated and participated in the online joint free clinic project for neurologists in 30 provinces.

 

2019

December

Awarded the “Top Employer China 2020”.

December

Jointly launched the project of “Yi-Lu-Wei-Ai – 2019 famous doctors going to the grassroots level” with the Red Cross Foundation of China.

October

Donated and joined the “memory of love – cognitive care program“.

October

Actively participated in the 2nd session for “large scale advocacy public welfare activities of Alzheimer’s disease“.

August

No. 86 in China’s top 100 pharmaceutical industry companies in 2018.

August

2019 Greater Suzhou Best Employer.

July

Carried out hhc activity of “Wei-Ai-Qi-Hang” into the community in Shanghai.

July

To Donate 350,000 yuan to China Population Welfare Foundation for the Project of “Public Welfare Stars Invite You to Help the Elderly with Cognitive Impairment Go Home”, which was jointly organized by China Population Welfare Foundation and Tencent News.

June

Supports “Health to Countryside” Project to Donate Drugs Worth of about RMB 530,000 yuan to the Qinghai Red Cross Society.

June

“Eisai Scholarship” Award Ceremony was held in China Pharmaceutical University.

May

460,000 yuan Donated to China Population Welfare Foundation.

April

2017-2018 Shanghai Civilization Unit.

March

Eisai China Scholarship Awards in Peking University health Science Center, Sun Yat-sen University, China Medical University, Fudan University School of Basic Medical, Shenyang Pharmaceutical University, Sichuan University West China Medical Center.

February

The 2018 Most Socially Responsible Enterprises in Suzhou Industrial Park (Credit Management).

February

2018 Jing’an District Economic Contribution Award.

January

Lenvima awarded Top Ten Innovative Drugs of the Year 2018 in the 11th Healthy China Forum.

 

2018

October

The Honorary Credential Granted Eisai China Inc. of Health to Countryside.

August

2018 Suzhou Best Employer Award

August

Eisai China harvested the 84th place in the 2016 China Top 100 Pharmaceutical Enterprises List announced by China National Pharmaceutical Industry Information Center.

March

Woman Civilization Station

March

Eisai China Scholarship Awards in Peking University health Science Center, Sun Yat-sen University, China Medical University, Fudan University School of Basic Medical, Shenyang Pharmaceutical University, Sichuan University West China Medical Center, Suzhou University.